skip to Main Content
Preclinical Studies Of API Longolytin Have Been Completed

Preclinical studies of API Longolytin have been completed

Preclinical studies of API Longolytin have been successfully completed.  Studies of toxicity and pharmacology have shown complete safety and efficiency of the drug.

Leave a Reply

Your e-mail address will not be published. Required fields are marked *